Saudi Arabia Clinical Trials Market & Regulations Insight 2025 - A US$ 200 Million Market Opportunity
The 'Saudi Arabia Clinical Trials Market, Ongoing Clinical Trials by Company, Indication, Phase & Regulations Insight 2025" report has been added to ResearchAndMarkets.com's offering.
Report Highlights
Saudi Arabia Clinical Trials Market Opportunity: US$ 200 Million
Comprehensive Insight on Clinical Trials Studies in Saudi Arabia: > 400 Studies
Clinical Trials Studies by Indication, Phase & Sponsor
Regulatory Framework & Clinical Trials Guidelines
Insight on Domestic CRO Operating in Saudi Arabia: 15 CRO
Overview on Existing Healthcare Infrastructure & Medical Professionals Like Doctors, Dentist, Nurses
Saudi Arabia is making significant strides in expanding its clinical research sector, aligning with the broader objectives of Vision 2030, which prioritizes scientific advancement and innovation. The Saudi government is actively enhancing research education and investing in clinical trials to improve healthcare outcomes. A key player in this transformation is the Saudi National Institute of Health (NIH), which has launched several initiatives to raise the quality and quantity of research conducted within the country. These efforts include establishing cutting-edge research facilities, fostering an environment where clinical trials can thrive, and setting new benchmarks for excellence.
By strengthening its focus on clinical trials, Saudi Arabia aims to develop medical treatments tailored to its population's specific genetic and health profiles. This is particularly important given the high prevalence of conditions such as diabetes and cardiovascular diseases, which require targeted treatment approaches. Addressing these health challenges through locally relevant clinical research ensures that therapies are better suited to the Saudi population, improving both patient outcomes and the overall healthcare system.
A closer look at the therapeutic areas of focus reveals that oncology, endocrinology, cardiology, and infectious diseases dominate Saudi Arabia's clinical trial landscape. These fields have attracted significant attention due to their widespread impact on public health. Pharmaceutical companies play a crucial role in this ecosystem, serving as the primary sponsors of most clinical trials, particularly multinational studies that require extensive resources and collaboration. Meanwhile, local researchers are actively involved in studies that focus specifically on the Saudi population, addressing region-specific health concerns.
Geographically, the majority of clinical trial sites are concentrated in urban centers, with Riyadh serving as the leading hub for research activities. The Makkah region and the Eastern Province also play significant roles, reflecting a broader trend where research efforts are primarily centered in areas with well-established medical infrastructure and access to specialized expertise. This concentration of research activity enables more efficient coordination of trials and facilitates collaborations between healthcare institutions, regulatory bodies, and industry stakeholders.
As Saudi Arabia's clinical research landscape continues to develop, there has been a noticeable rise in the number of clinical trial applications under review. The Saudi Food and Drug Authority (SFDA) is working diligently to strengthen its regulatory framework, ensuring that all studies meet stringent safety and efficacy standards. This regulatory progress is crucial as the country seeks to attract more international multicenter trials, allowing it to integrate into the global clinical research ecosystem.
The SFDA's efforts include refining approval processes, implementing robust monitoring systems, and ensuring compliance with international best practices. These improvements are particularly vital as Saudi Arabia moves toward more sophisticated trial designs, including precision medicine approaches and innovative drug development strategies.
Additionally, the country is placing greater emphasis on translational research, bridging the gap between laboratory discoveries and real-world clinical applications. By fostering a research-friendly environment and maintaining high regulatory standards, Saudi Arabia is positioning itself as a key player in the global clinical trials landscape, driving advancements that will shape the future of healthcare both regionally and beyond.
Key Topics Covered:
1. Saudi Arabia Clinical Trials Market Outlook
1.1 Current Scenario
1.2 Future Growth Outlook
2. Saudi Arabia Pharmaceutical Market Analysis
2.1 Overview
2.2 Regulatory Framework
2.3 Branded v/s Generic Drugs Availability
3. Saudi Arabia Clinical Trials Overview
3.1 by Phase
3.2 by Sponsors
4. Saudi Arabia Clinical Trials Insight by Company, Indication & Phase
4.1 Phase I
4.2 Phase I/II
4.3 Phase I/IIIB
4.4 Phase II
4.5 Phase II/III
4.6 Phase III
4.7 Phase IV
4.8 Phase BE
5. Saudi Arabia Clinical Trials Regulatory Framework & Guidelines
5.1 Overview
5.2 Drug Safety Monitoring Initiatives
5.3 Regulations For Conducting Clinical Trials on Drugs
5.4 Regulation For Drugs Approval
5.5 Guidelines For Investigational New Drugs (IND)
6. Healthcare Infrastructure & Manpower in Saudi Arabia
7. Saudi Arabia Clinical Trials Market Dynamics
7.1 Drivers & Opportunities
7.2 Challenges & Restraints
8. Clinical Research Organizations Operating in Saudi Arabia
ArabMed CRO
Baahith
Balsam Clinical Research
CLINLIA
ClinServ International
CTI
KAU Med CRO
MCT CRO
Mesned
Monitoring Force Gulf Limited
PDC CRO
Phoenix Clinical Research
RAY CRO
SALA CRO
SGS
For more information about this report visit https://www.researchandmarkets.com/r/lulo4c
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS
SOURCE: Research and Markets
Copyright Business Wire 2025.
PUB: 03/10/2025 08:10 AM/DISC: 03/10/2025 08:10 AM
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
RFK Jr. includes vaccine misinformation spreaders among newly announced ACIP members
Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday announced the new members of a key vaccine advisory committee, just days after he fired all sitting members in what he called 'a clean sweep.' The eight new voting members of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) represent a significant downsizing from the 17 who previously served. Kennedy in a post on the social platform X said the new members will meet as scheduled on June 25 to discuss the COVID-19 vaccine. They will review safety and efficacy data for the current schedule as well, he said. 'The slate includes highly credentialed scientists, leading public-health experts, and some of America's most accomplished physicians. All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense,' he added. The eight new ACIP members announced by Kennedy are: Joseph R. Hibbeln, a psychiatrist and neuroscientist who worked on nutritional neurosciences at the National Institutes of Health (NIH). Martin Kulldorff, an epidemiologist formerly at Harvard Medical School. Retsef Levi, a professor of operations management at the Massachusetts Institute of Technology's Sloan School of Management. Robert W. Malone, a biochemist who took part in early research of mRNA vaccine technology. Cody Meissner, a professor of pediatrics at the Geisel School of Medicine at Dartmouth College who previously served on ACIP. James Pagano, an emergency medicine physician. Vicky Pebsworth, the Pacific region director of the National Association of Catholic Nurses. She formerly sat on the Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee. Michael A. Ross, a clinical professor of obstetrics and gynecology at George Washington University and Virginia Commonwealth University. Kennedy on Tuesday said that none of the new ACIP members will be 'ideological anti-vaxxers,' but some of the new members are well-known COVID-19 contrarians and are known for spreading vaccine misinformation. Malone, who claims to be the inventor of mRNA vaccines despite what those who've worked with him say, became a fixture of conservative media during the pandemic. He promoted the use of hydroxychloroquine and ivermectin for treating the coronavirus and repeatedly claimed the COVID shots did not work. Kulldorff was one the leading authors of the Great Barrington Declaration, along with current NIH Director Jay Bhattacharya. Kennedy fired all 17 sitting members of ACIP on Monday, claiming a 'clean sweep is needed to re-establish public confidence in vaccine science.' The ACIP is an independent, expert panel that provides guidance on vaccine recommendations. The sweeping, abrupt firing of all sitting ACIP members this week was met with alarm and concern, with groups like the American Nurses Association saying it could further 'erode public confidence' in vaccines. The move also directly contradicted an assurance that Kennedy had given to Sen. Bill Cassidy (R-La.), chair of the Senate Committee on Health, Education, Labor and Pensions, when he said he would 'maintain the [ACIP] without changes.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
Israeli gunfire, strikes kill 120 Palestinians in Gaza, many at aid sites
Israeli forces have killed more than 120 Palestinians across the Gaza Strip in the last 24 hours, medical sources have told Al Jazeera, including dozens of hungry aid seekers, as Israel continues to relentlessly bombard the besieged territory, with the overall war death toll now surpassing a staggering 55,000 people. Gaza's Health Ministry said 57 people trying to access aid were killed and more than 363 injured by Israel since Wednesday morning. The distribution points are operated by the controversial Gaza Humanitarian Foundation (GHF), a US- and Israeli-backed drive in tightly Israeli-controlled zones. Israel's Foreign Ministry has described the GHF aid system as a 'dramatic success' despite mass killings and scenes of utter human desperation, triggering widespread international opprobrium. The isolated aid sites – set up in Rafah and in the Netzarim Corridor – have been branded 'human slaughterhouses' as more than 220 people have been killed while desperately trying to secure meagre food parcels for their families since GHF started operating on May 27. The Israeli army has admitted its troops fired 'warning shots' in the area of the Netzarim Corridor, where the majority of aid seekers were reported killed overnight. Gaza's Government Media Office said the Israeli military 'is deliberately creating chaos in the Gaza Strip by perpetuating a policy of starvation and deliberately targeting and killing starving people seeking food'. The United Nations also condemned the killings and has refused to supply aid via the foundation, which uses private contractors with Israeli military backup in what the UN says is a breach of humanitarian standards. The UN Relief and Works Agency for Palestine Refugees (UNRWA) called the aid distribution model 'a distraction from the ongoing atrocities and a waste of resources'. It reiterated that the humanitarian community in Gaza, including UNRWA, is 'ready and has the experience and expertise to reach people in need'. Israel has banned UNRWA and other legacy aid agencies with decades of experience from operating in Gaza, where a famine looms, while it maintains a punishing aid blockade. Chris Newton, a senior analyst at the International Crisis Group, said Israel's chaotic and violence-plagued aid system is deliberately structured to keep Palestinians desperate and hungry while pushing them southward. Newton told Al Jazeera that GHF's stated aim of providing 1,750 calories worth of food per person per day is well short of the minimum standard for crisis situations. That amount of food is 'closer to the ration given in a starvation experiment run in the 1940s in the US than it is to Israel's own previous 2008 red line for the minimum calories needed to avoid malnutrition in Gaza,' said Newton. Elsewhere in Gaza on Wednesday, dozens of other people were killed by Israeli gunfire and strikes across the coastal territory. An Israeli attack in Gaza City's Tuffah neighbourhood killed at least seven people, according to local medical sources. Three Palestinians, including two children, were killed when an Israeli strike hit a home in northern Gaza's Jabalia, while in central Gaza's Nuseirat refugee camp, three more Palestinians were killed in an Israeli drone strike, which wounded several others, according to the news agency Wafa. In southern Gaza's Khan Younis, Israeli air strikes on displacement tents in the Tiberias camp killed four Palestinians, including a child, and wounded others, Wafa have borne much of the brunt of Israel's ongoing assault. Gaza's Health Ministry said the total death toll from Israel's war has risen to 55,104 since October 7, 2023 – most of them women and children. Al Jazeera's Hani Mahmoud, reporting from Gaza City, said al-Shifa Hospital, like many other health facilities, has been reduced in terms of its capacity to provide proper healthcare to people, let alone children. UNICEF spokesperson James Elder, who was at al-Shifa, said, 'Everywhere we go, this is the same scenario. 'Despite doctors' most incredible efforts, we see children being brutalised, burned … because it's a war on children.' In the meantime, Israel continues to hold some of the crew members and activists who were on board the Madleen aid vessel trying to break the Israeli siege. Israeli forces intercepted the vessel and its 12 crew members in international waters off Gaza earlier this week. While it deported four of the members, including Swedish activist Greta Thunberg, eight others remain in detention. The group Adalah–The Legal Center for Arab Minority Rights in Israel called on Israel to immediately release the remaining detained volunteers and return them either 'to the Madleen to resume their humanitarian mission to Gaza or to their countries of origin'.At least two of the detainees were placed in solitary confinement, according to their lawyers, though one – Rima Hassan – has since been returned to the main prison wing. Brazilian national Thiago Avila was placed in solitary at Ayalon Prison due to an 'ongoing hunger and thirst strike' that began this week. 'He has also been treated aggressively by prison authorities, although this has not escalated to physical assault,' Adalah said. Hassan, a French citizen and member of the European Parliament, was also temporarily placed in isolation in Neve Tirza Prison after writing 'Free Palestine' on a wall in another prison called Givon. The UN's special rapporteur on the occupied Palestinian territories, Francesca Albanese, has decried the arrests as 'arbitrary' and 'unlawful' and also called for the detainees' immediate release. The Israeli military says it recovered the bodies of Yair Yaakov and a second captive, whose name has not yet been released, in a joint operation in Khan Younis with the Israeli intelligence agency Shin Bet.
Axios
3 hours ago
- Axios
RFK Jr. names 8 new members of vax advisory panel
HHS Secretary Robert F. Kennedy on Tuesday named eight new members to serve on an influential federal vaccine advisory panel after firing all 17 of the committee's members. Why it matters: While Kennedy posted on X that the new appointees are committed to evidence-based medicine, several have a history of expressing anti-vaccine sentiment or voicing concerns about COVID-19 or mRNA vaccines. Some were also signers of the Great Barrington Declaration, a petition authored by a group of scientists including current NIH Director Jay Bhattacharya that advocated for allowing COVID to spread among young, healthy people to reach herd immunity faster. The approach drew fierce criticism from many experts. The Advisory Committee on Immunization Practices serves as an outside expert source to make recommendations to the Centers for Disease Control. Its recommendations can influence whether insurers cover vaccines. The new members are: Martin Kulldorf, a biostatistician who previously served on the Vaccine Safety Subgroup of ACIP and who was a co-author of the Great Barrington Declaration. He was fired from Harvard University for refusing COVID vaccination. He later claimed it was because he was " too pro-vaccine." Robert Malone, a physician-scientist and biochemist who made early contributions to mRNA vaccine technology. He was dubbed a "misinformation star" by the New York Times for spreading false information about COVID and mRNA shots, including claiming he was an inventor of the technology.. Cody Meissner, a professor of pediatrics at the Geisel School of Medicine at Dartmouth, who has previously held advisory roles for both CDC and FDA. He is also a signer of the Great Barrington Declaration and co-wrote an editorial with FDA Commissioner Marty Makary during the COVID pandemic arguing against masking for children. Retsef Levi, a professor of operations research at MIT. Levi has been a critic of mRNA vaccines, posting on social media in 2023 that "we have to stop giving them immediately." Vicky Pebsworth, a long-time nurse with a Ph.D. in public health. She previously served on the FDA's Vaccine and Related Biological Products Advisory Committee and on the National Vaccine Advisory Committee's vaccine safety working group for the H1N1 vaccine. As of 2022, Pebsworth served on the board of the National Vaccine Information Center, an anti-vaccine group. She's spoken publicly about her son experiencing long-term health issues following vaccines at 15 months old. Joseph Hibbeln, a psychiatrist and neuroscientist who previously worked at the NIH for many years. He primarily studies nutrition and brain health. Michael Ross, a clinical professor of obstetrics and gynecology at George Washington University and Virginia Commonwealth University. James Pagano, an emergency medicine physician licensed in Florida and California. The other side: The announcement immediately stoked fears from some public health experts that the committee selections are overly skeptical of vaccines. "It's entirely possible that some of these people may be completely non-problematic," Angela Rasmussen, a virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan. However, others are "unbelievably anti-vax people. They are 100% not going to approach this in good faith."
